IMVT - Immunovant  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IMVT is currently covered by 12 analysts with an average price target of $40.2. This is a potential upside of $10.78 (36.64%) from yesterday's end of day stock price of $29.42.

Immunovant 's activity chart (see below) currently has 55 price targets and 83 ratings on display. The stock rating distribution of IMVT is 95.92% BUY and 4.08% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.84% with an average time for these price targets to be met of 197.43 days.

Highest price target for IMVT is $52, Lowest price target is $36, average price target is $40.2.

Most recent stock forecast was given by DANIELLE BRILL from RAYMOND JAMES on 10-Oct-2024. First documented stock forecast 07-Jan-2020.

Currently out of the existing stock ratings of IMVT, 47 are a BUY (95.92%), 2 are a HOLD (4.08%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$36

$6.61 (22.49%)

$40

26 days ago
(10-Oct-2024)

2/3 (66.67%)

$6.07 (20.28%)

35

Buy

$51

$21.61 (73.53%)

$51

1 months 6 days ago
(30-Sep-2024)

12/18 (66.67%)

$22.49 (78.88%)

279

Buy

1 months 27 days ago
(09-Sep-2024)

4/5 (80%)

$7.25 (19.21%)

113

Buy

$41

$11.61 (39.50%)

$56

2 months 23 days ago
(13-Aug-2024)

1/5 (20%)

$11.21 (37.63%)

3

Buy

$48

$18.61 (63.32%)

$48

7 months 11 days ago
(25-Mar-2024)

7/11 (63.64%)

$16.78 (53.75%)

275

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IMVT (Immunovant ) average time for price targets to be met?

On average it took 197.43 days on average for the stock forecasts to be realized with a an average price target met ratio 71.84

Which analyst has the current highest performing score on IMVT (Immunovant ) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on IMVT (Immunovant )?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on IMVT

Which analyst is the currently most bullish on IMVT (Immunovant )?

Yasmeen Rahimi with highest potential upside - $27.61

Which analyst is the currently most reserved on IMVT (Immunovant )?

Tiago Fauth with lowest potential downside - -$22.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?